Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

CELGENE

(CELG)
  Report
 SummaryChartsNewsCompanyFinancials 
Estimated financial data (e) (USD)
Sales 2017 13 003 M - -
Net income 2017 2 940 M - -
Net Debt 2017 3 793 M - -
P/E ratio 2017 28,7x
Yield 2017 -
Sales 2018 15 281 M - -
Net income 2018 4 046 M - -
Net Debt 2018 14 221 M - -
P/E ratio 2018 11,6x
Yield 2018 -
Capitalization 77 036 M 77 036 M -
EV / Sales 2017 6,61x
EV / Sales 2018 3,86x
Nbr of Employees 8 852
Free-Float -
More Financials
All news about CELGENE
09/07Biocon Limited, Biocon Pharma Limited and Biocon Pharma Inc. Enters into A Confidential..
CI
08/04CELGENE : Sun Pharma And Celegene Settle Patent Dispute Over Lenalidomide (Revlimid«)
AQ
07/09BESRA GOLD INC : Announces Lodgment of Replacement Prospectus & Adjournment of Note Holder..
NE
06/21Celgene Corporation Will Grant Sun Pharmaceutical Industries Limited A License to Celge..
CI
04/14CELGENE : Rocket docket pharma patent litigation taking off in Australia and other emergin..
AQ
04/07DGAP-WPÜG : Tender Offer / Target company: ; Bidder: qqqqq
EQ
03/25Cadila Healthcare Limited - Zydus Announces Settlement of Patent Litigation for Generic..
AQ
03/25Leonteq becomes new issuer on BX Swiss – “deriBX”
TE
02/23BRISTOL MYERS SQUIBB CO : Other Events (form 8-K)
AQ
02/23Bristol Myers Squibb and Celgene Issue Notices of Redemption and Partial Redemption of ..
AQ
02/22Celgene Corporation Issues Notice of Redemption of Notes
CI
02/04Bristol-Myers Squibb Company and Celgene Corporation Announce Tender Offers for an Aggr..
CI
01/05Ikena Oncology, Inc. announced that it has received $120 million in funding from a grou..
CI
2020AMGEN : Signs Licensing Agreement With Medicines Development for Global Health
MT
2020BRISTOL MYERS SQUIBB : Q3 Results Beat Estimates; Raises 2020 EPS Outlook
MT
More news
News in other languages on CELGENE
04/07DGAP-WPÜG : Angebot zum Erwerb / Zielgesellschaft: ; Bieter: qqqqq
03/25Leonteq wird neue Emittentin an der BX Swiss AG im Segment źderiBX╗
02/02BX Swiss AG startet Handel in neuem Bondsegment
2020Die BX Swiss AG erhält von der FINMA die Zulassung zur Führung des Schweizer Beraterreg..
2020Möbel Markt mömax wird neuer Ankermieter im Rüti Center in Pratteln
More news
Analyst Recommendations on CELGENE
More recommendations
Chart CELGENE
Duration : Period :
Celgene Technical Analysis Chart | CELG | MarketScreener
Income Statement Evolution
Managers and Directors
Matt M. Roden President & Director
David V. Elkins CFO, Principal Accounting Officer & Executive VP
P. Joseph Campisi Director & Vice President
Katherine Reynolds Kelly Secretary & Director
Jeffrey Galik Treasurer